• Biocartis announces market release of SeptiCyte® RAPID test on Idylla™

    Tuesday October 6th 2020

  • Mithra announces FDA update

    Tuesday October 6th 2020

  • argenx expands capabilities in antibody engineering through key technology partnerships

    Tuesday October 6th 2020

  • Hedwig Maes appointed new CEO of Agidens

    Monday October 5th 2020

  • Bone Therapeutics, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia

    Monday October 5th 2020

  • argenx presents additional Efgartigimod data from Global Phase 3 ADAPT Trial

    Monday October 5th 2020

  • Biocartis joins COVID-19 Testing Industry Consortium of nineteen healthcare community organizations

    Thursday October 1st 2020

  • Imec announces whole genome data analysis available in just a few hours

    Thursday October 1st 2020

  • Your news here?

  • Biotalys awarded €1.1 million VLAIO research grant

    Thursday October 1st 2020

  • Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial

    Wednesday September 30th 2020

  • Biocartis receives EUR 1.2 million grant for development of highly innovative Idylla™ GeneFusion Assay

    Wednesday September 30th 2020


Strategic Partners